Acute Obstructive Pulmonary Disease And Pancreatitis Essay

I will analyse the prevalence of the condition and what the potential causes may be. My interests have been directed to pre hospital care and community lead treatment packages, which are potentially available to the patient, as this is the acute environment, which I will have contact with in my employment as a paramedic. The initial reading was to understand COPD as a chronic condition, what is COPD? and its prevalence in the population. The (World health organisation, 2000), states that one in four deaths in the world are caused by COPD. In 2010 (Vos T Flaxman etal, 2012), says globally there were approximately 329 million, which is 4.8% of the population who are affected by this chronic condition, In the UK (NICE, 2010), have estimated that 3 million people suffer from COPD, with more yet to be diagnosed. This information about the amount of people living with this condition was surprising, as I little knowledge of its existence. During the early 1960’s (Timothy Q. Howes, 2005), says the term COPD had been designated as a single term unifying all the chronic respiratory diseases. Since then the term COPD, has been sub divided in to three umbrella areas, Bronchitis, Emphysema and Chronic asthma, which are separate conditions, which I have been previously aware of as their individual conditions. The 58 year old patient who we visited,

There are no cure for this disease. However, there are different treatment to prevent further deterioration of the lungs function in order to improve the quality of life of the patient by increasing capacity of their physical activity. One of the main severe complication a patient with COPD can develop is exacerbation. Increased breathlessness, increased sputum volume and purulent sputum are the signs and symptoms of exacerbation. Early detection of the signs of exacerbation can help keep the condition of the patient from worsening. The treatments of COPD mainly aims at controlling the symptoms of exacerbation such as taking inhalers. Patients who are over the age of 35 and ex-smokers with chronic cough and bronchitis are recommended to have spirometer (NICE, 2004). This is because it is possible to delay or prevent patients from developing severe case of COPD is identified before they lose their lungs functions. Oxygen therapy is another treatment for COPD as the patients with this condition has high

The topic is Chronic Obstructive Pulmonary Disease (COPD). It is an umbrella term used for respiratory disorders such as chronic asthma, chronic bronchitis and emphysema. It is a serious condition that restricts airflow to the lungs and is not fully reversible. It is a major cause of morbidity and mortality in Australia. More than 1 in 20 Australians over 55 have COPD and is also the fifth leading cause of death. There is also a rate of 1,008 per 100,000 of the population aged 55 and over being hospitalized for the condition. The rates among Aboriginal and Torres Strait Islanders compared with non-indigenous Australians are 2.5 times as high (Australian Institute of Health and Welfare, 2016). There is no cure however; the management can slow the disease progression and is therefore crucial to the quality of life of patients.

Accordingly, to this information of COPD: Coping with COPD from PubMed Health, this article provides the early stages, progression, coping and emergency plan and this disease affects family and friends. It is written answering the question, what to expect from COPD and how to manage this lung disease? A team of health care professionals, scientists and editors, and experts (Chronic obstructive pulmonary disease (COPD), 2015), provides education of how this disease may affect daily lives, how to live with this disease and what causes

The study included 100 patients with COPD. All patients fulfilled the inclusion and exclusion criteria. According to its demographic and clinical parameters and treatment groups differ among themselves. Completed the study, all patients included in the study. The therapy in all patients with a clinically meaningful improvement of symptoms was observed.

Another treatment is and oxygen treatment which gives you extra oxygen and you wear a mask which you can carry with you or go to the doctor. Some have small oxygen where you carry in backpack but you would need to carry with you at all times. Lastly, surgery with is not really used when someone has COPD and only for those whom have a severe COPD and the treatment does not improve with other treatment listed above. Prevention really is to just stop smoking and exposure to

The main symptoms of COPD are long lasting cough, mucus that come up when you cough, and when you exercise (or even just walk up the stairs) shortness of breath can get worse. When COPD gets worse, it gets harder to eat or exercise, and breathing takes much more energy. People often lose weight and get weaker. Symptoms might even flare up and get much worse. This is called COPD exacerbation. An exacerbation can range from mild to life threatening. The longer you have this disease, the more severe the flare up can get.

In order to treat this disease, smokers need to participate in smoking cessation which involves the most important step, to stop smoking. Medications to help treat COPD include bronchodilators, such as inhalers, which relax muscles around the air way. Inhaled steroids can reduce air way inflammation and help prevent exacerbations. Lung therapies include oxygen therapy which will help increase blood oxygen. If severe enough, surgeries such as lung volume reduction surgery, lung transplants, and a bullectomy may be

Chronic obstructive pulmonary disease, commonly known as COPD, is a collection of lung conditions or diseases that, all together, block the flow of air into the lungs. This condition makes it hard for the patient have dyspnea, anoxia, or eventually apnea. COPD usually starts off small and gradually gets worse and worse over time, hints chronic in its name. Because it starts off small there are many people who have this disease but do not know it until it is further along and worse. This disease is very common for both smokers and nonsmokers and is a bigger threat to our health than most people think. < Victor >< MacGill >

Patients will usually have the symptoms seen in asthma, emphysema and chronic bronchitis. Exposure to noxious stimuli such as cigarette smoke is a major cause of COPD. Symptoms include productive cough, shortness of breath and wheezing (Nagelmann et al., 2011).

Chronic obstructive pulmonary disease (COPD) is preventable disease that has a detrimental effects on both the airway and lung parenchyma (Nazir & Erbland, 2009). COPD categorises emphysema and chronic bronchitis, both of which are characterised by a reduced maximum expiratory flow and slow but forced emptying of the lungs (Jeffery 1998). The disease has the one of the highest number of fatalities in the developed world due to the ever increasing amount of tobacco smokers and is associated with significant morbidity and mortality (Marx, Hockberger & Walls, 2014). Signs and symptoms that indicate the presence of the disease include a productive cough, wheezing, dyspnoea and predisposing risk factors (Edelman et al., 1992).

Management is diverse, the objective is to relief from symptoms, delay progression, increase exercise tolerance and reduce mortality; this can be accomplished by preventing and treating complications (Nettina, 2013). Since smoking is so rampant in this patient, it is critical that the nurse translates the importance of smoking cessation to slow disease advancement and increase survival (Nettina, 2013). Another standard treatment of COPD is the use of inhaled bronchodilators that reduce dyspnea and bronchospasm (Nettina, 2013). Some of these medications are long acting, such as the anticholinergic Tiotropium or the beta adrenergic agonists Salmeterol, others are short acting, used before activity or when symptoms worsen; examples of such are Ipratropium, an anticholinergic, and the beta adrenergic agonists Albuterol (Nettina, 2013).The patient that has repeated exacerbations and is symptomatic with a FEV1 less than fifty percent is often prescribed inhaled corticosteroids (Nettina. 2013). Those experiencing an acute exacerbation are prescribed oral corticosteroids due to their anti-inflammatory attributes (Nettina, 2013). All of these inhaled medications require the nurse to provide extensive teaching on proper use of the types of inhalers, as well as, the importance of the taking as prescribed; this is also the case of the oral corticosteroid

Chronic Obstructive Pulmonary Disease, also known as COPD, is the third leading cause of death in the United States. COPD includes extensive lungs diseases such as emphysema, non-reversible asthma, specific forms of bronchiectasis, and chronic bronchitis. This disease restricts the flow of air in and out of the lungs. Ways in which these limitations may occur include the loss of elasticity in the air sacs and throughout the airways, the destruction of the walls between air sacs, the inflammation or thickening of airway walls, or the overproduction of mucus in airways which can lead to blockage. Throughout this paper I am going to explain the main causes, symptoms, diagnosis, and ways to reduce COPD.

According to (Rosdahl & Kowalski , 2012)Pancreatitis is known as inflammation of the pancreas .it may develop from infectious or traumatic damage , alcohol , or drugs . cysts may occasionally occur . pancreatitis are of two types acute or chronic . bile does not enter the pancreas ; if

Chronic pancreatitis is not commonly diagnosed in children. No pediatric-specific epidemiology is available, the incidence of chronic pancreatitis increases with age. Though uncommon in pediatric age group it is associated with significant morbidity and mortality. It is characterized by inflammation of the pancreas, clinical signs of epigastric abdominal pain, and elevated serum lipase or amylase and evidence of radiological pancreatic inflammation